Skip to main content

Table 1 Baseline characteristics of participants in the ARK study and this case-control study

From: Proteomic insights into the pathophysiology of hypertension-associated albuminuria: Pilot study in a South African cohort

Variable

Overall ARK study

(N = 2,021)

Cases

(n = 24)

Controls

(n = 49)

P valuea

Age (years), mean (SD)

38 (14)

38 (13)

42 (14)

0.255

Sex - Male, n (%)

851 (42)

16 (67)

31 (63)

0.776

BMI Kg/m2, mean (SD)

27 (6)

31 (7)

26 (7)

0.005

eGFR (ml/min/1.73m2),b mean (SD)

112 (18)

101 (23)

116 (14)

0.044

UACR (mg/mmol), median (IQR)

0.4 (0.2–1.2)

9.4 (4.5–18.7)

0.4 (0.2–0.7)

<0.001c

Systolic blood pressure mm Hg, mean (SD)

128 (17)

162 (20)

123 (9)

<0.001

Diastolic blood pressure mm Hg, mean (SD)

78 (11)

98 (14)

74 (7)

<0.001

Hypercholesterolaemia,d n (%)

465 (23)

9 (38)

13 (27)

0.337

APOL1low-risk (zero or one risk allele), n (%)

1,776 (89)

19 (79)

37 (76)e

0.965

APOL1high-risk (two risk alleles), n (%)

226 (11)

5 (21)

10 (20)e

0.965

  1. aComparison between cases and controls. bMeasured using the Chronic Kidney Disease Epidemiology (CKD-EPI) equation. cT-test performed on log-transformed data. dNon-fasting total cholesterol >5.0mmol/L. eUnable to interpret APOL1 status in two controls
  2. APOL1, Apolipoprotein L1; BMI, body mass index; eGFR, estimated glomerular filtration rate; IR, interquartile range; SD, standard deviation; UACR, urine albumin-to-creatinine ratio